This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BF.B Misses Q1 Earnings & Sales Estimates on Soft Volume, Stock Dips
by Zacks Equity Research
Brown-Forman's Q1 results reflect soft volume trends and dismal performances across brands and geographies, leading to soft sales and profitability.
Dollar General Misses Q2 Earnings, Lowers View on Soft Sales Trends
by Zacks Equity Research
Dollar General trims its fiscal 2024 guidance due to sluggish sales trends. DG now envisions net sales growth between 4.7% and 5.3%.
Campbell Soup's Q4 Earnings Top Estimates, Organic Sales Dip
by Zacks Equity Research
Campbell Soup's Q4 results reflect gains from the Sovos Brands buyout and supply-chain productivity. CPB's organic sales fall due to adverse net price realization.
The J.M. Smucker Q1 Earnings Top Estimates, SJM Stock Down on View Cut
by Zacks Equity Research
J.M.Smucker's Q1 show reflects sales and earnings growth despite a tough consumer landscape. SJM cuts view due to a dynamic landscape and green coffee costs.
CENT Stock Declines 11% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
Central Garden & Pet Company is facing softness in new pet adoptions as well as lower foot traffic at home center retailers.
Hain Celestial Q4 Earnings Top, Hain Reimagined Strategy Yields
by Zacks Equity Research
HAIN's fourth-quarter fiscal 2024 results show increased earnings on the back of the effectiveness of the Hain Reimagined strategy despite a year-over-year decline in sales.
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
by Zacks Equity Research
Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
BJ's Wholesale (BJ) Stock Falls Despite Q2 Earnings Beat, Comps Growth
by Zacks Equity Research
BJ's Wholesale Club's (BJ) second-quarter earnings results reflect growth in digitally enabled comparable sales. The metric surges 22% during the quarter.
Ollie's (OLLI) Expands Supply With New Distribution Hub
by Zacks Equity Research
Ollie's (OLLI) expansion of its distribution center in Princeton underscores the company's commitment to delivering exceptional value to customers.
Are Investors Undervaluing Associated British Foods (ASBFY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Coca-Cola Europacific Partners (CCEP) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Coca-Cola European (CCEP) and Chefs' Warehouse (CHEF) have performed compared to their sector so far this year.
COTY's Q4 Loss Wider Than Estimates, Sales Increase Y/Y
by Zacks Equity Research
COTY's fourth-quarter fiscal 2024 results reflect growth in the Consumer Beauty segments. However, the bottom line declines year over year.
Target (TGT) Q2 Earnings Beat Estimates, Comps Rise Y/Y
by Zacks Equity Research
Target (TGT) achieves comparable sales growth in the second quarter, rebounding from past challenges. The retail bellwether witnesses increased traffic both in stores and across digital channels.
Conagra Brands (CAG) Troubled by Slowdown in Consumption Trends
by Zacks Equity Research
Conagra Brands (CAG) has been witnessing challenging industry trends, including a slowdown in consumption. The company expects volumes to be soft in the first quarter of fiscal 2025.
Lowe's (LOW) Q2 Earnings Beat, Comps Fall & FY24 Outlook Cut
by Zacks Equity Research
Lowe's (LOW) second-quarter fiscal 2024 results reflect a reduction in Do-It-Yourself discretionary spending. Comparable sales for the quarter decline 5.1%.
United Natural (UNFI) Stock Down More Than 15% YTD: Here's Why
by Zacks Equity Research
United Natural (UNFI) is battling challenges like reduced consumer spending, weakness in the Retail business and margin pressure.
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
by Zacks Equity Research
Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.
3 Reasons Growth Investors Will Love Chefs' Warehouse (CHEF)
by Zacks Equity Research
Chefs' Warehouse (CHEF) possesses solid growth attributes, which could help it handily outperform the market.
Flowers Foods (FLO) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Flowers Foods' (FLO) second-quarter fiscal 2024 results reflect higher earnings on strong operational performance. However, sales decline year over year due to lower volumes.
Estee Lauder (EL) Q4 Earnings Top, Asia Travel Retail Sluggish
by Zacks Equity Research
Estee Lauder's (EL) Q4 results reflect increased earnings and sales despite sluggishness in core business areas, especially mainland China, Asia travel retail and North America.
Helen of Troy's (HELE) Stock Down More Than 57% YTD: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is facing a tough operational environment, heightened macroeconomic uncertainty and a financially-strained consumer environment.
Kellanova (K) Stock Jumps 10% in a Week: What's the Buzz About?
by Zacks Equity Research
Kellanova's (K) stock surge follows Mars' plan to acquire the company. The deal aligns well for both companies, with Kellanova set to gain from Mars' global reach and resources.
Here's Why Sprouts Farmers (SFM) Has Rallied 25% in 3 Months
by Zacks Equity Research
Sprouts Farmers (SFM) is expanding its customer base through product innovation and targeted marketing.
Molson Coors' (TAP) Revitalization Plan & Innovation Aid
by Zacks Equity Research
Molson Coors (TAP) enjoys the benefits from its revitalization plan, product portfolio and expansion in growth areas.
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
by Zacks Equity Research
Medifast (MED) is encountering difficulties in attracting customers due to a reduction in the number of active OPTAVIA Coaches and diminished productivity per Coach.